Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9

Journal of Bone and Mineral Research

Volumn 14, Issue 5, 1999, Pages 757-763

  Xie, Wei Fen ^a   Zhang, Xin ^a   Sakano, Shinji ^a   Lefebvre, Véronique ^b   Sandell, Linda J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RETINOIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CHONDROGENESIS; FIBROBLAST; GENE EXPRESSION REGULATION; MESENCHYME CELL; NONHUMAN; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN ISOLATION; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0032922670     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.5.757     Document Type: Article

References (37)

1. Davis RL, Weintraub H, Lassar AB 1987 Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
2. Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156.
3. Kim JB, Spiegelman BM 1996 ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10:1096-1107.
4. Molkentin JD, Black BL, Martin JF, Olson EN 1995 Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136.
5. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
6. Cancedda R, Cancedda FD, Castagnola P 1995 Chondrocyte differentiation. Int Rev Cytol 159:265-358.
7. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN, Brook JD, Schafer AJ 1994 Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
8. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, Wolf U, Tommerup N, Schempp W, Scherer G 1994 Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120.
9. Giese K, Cox J, Grosschedl R 1992 The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69:185-195.
10. Wright EM, Snopek B, Koopman P 1993 Seven new members of the Sox gene family expressed during mouse development. Nucleic Acids Res 21:744.
11. Harley VR, Lovell-Badge R, Goodfellow PN 1994 Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 22:1500-1501.
12. Grosschedl R, Giese K, Pagel J 1994 HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures. Trends Genet 10:94-100.
13. Connor F, Cary PD, Read CM, Preston NS, Driscoll PC, Denny P, Crane-Robinson C, Ashworth A 1994 DNA binding and bending properties of the postmeiotically expressed Sry-related protein Sox-5. Nucleic Acids Res 16:3339-3346.
14. Connor F, Wright E, Denny P, Koopman P, Ashworth A 1995 The Sry-related HMG box-containing gene Sox6 is expressed in the adult testis and developing nervous system of the mouse. Nucleic Acids Res 23:3365-3372.
15. Wright E, Hargrave MR, Christiansen J, Cooper L, Kun J, Evans T, Gangadharan U, Greenfield A, Koopman P 1995 The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 9:15-20.
16. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B 1997 SOX9 is a potent activator of the chondrocyte-specific enhancer of the proal(II) collagen gene. Mol Cell Biol 17:2336-2346.
17. Bell DM, Leung KKH, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PPL, Cheah KSE 1997 SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174-178.
18. Ng LJ, Wheatly S, Muscat GEO, Conway-Campbell J, Bowles J, Wright E, Bell DM, Tam PPL, Cheah KSE, Koopman P 1997 SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183:108-121.
19. Zhao Q, Eberspaecher H, Lefebvre V, de Crombrugghe B 1997 Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209:377-386.
20. Blesch A, Bosserhoff AK, Apfel R, Behl C, Hessdoerfer B, Schmitt A, Jachimczak P, Lottspeich F, Buettner R, Bogdahn U 1994 Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res 54:5695-5701.
21. Dietz UH, Sandell LJ 1996 Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem 271:3311-3316.
22. Bosserhoff AK, Kondo S, Moser M, Dietz UH, Copeland NG, Gilbert DJ, Jenkins NA, Buettner R, Sandell LJ 1997 Mouse CD-RAP/MIA gene: Structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn 208:516-525.
23. Lu J, Pei H, Kaeck M, Thompson HJ 1997 Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog 20:204-215.
24. Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R, Stolz W, Buettner R 1997 Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 57:3149-3153.
25. Xie WF, Kondo S, Sandell LJ 1998 Regulation of the mouse cartilage-derived ietinoic acid-sensitive protein gene by the transcription factor AP-2. J Biol Chem 273:5026-5032.
26. 3 on cartilage differentiation in a clonal chondrogenic cell population. Endocrinology 125:2103-2110.
27. Franceschi RT, Iyer BS, Cui Y 1994 Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 9:843-854.
28. Mukhopadhyay K, Lefebvre V, Zhou G, Garofalo S, Kimura JH, de Crombrugghe B 1995 Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific element and to define active promoter segments in the mouse pro-α1 (II) collagen gene. J Biol Chem 270:27711-27719.
29. Aiyar A, Leis J 1993 Modification of the megaprimer method of PCR mutagenesis: Improved amplification of the final product. Biotechniques 14:366-368.
30. Südbeck P, Schmitz ML, Baeuerle PA, Scherer G 1996 Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat Genet 13:230-232.
31. Sandell LJ, Nalin AM, Reife RA 1994 Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev Dyn 199:129-140.
32. Yoshioka H, Iyama KI, Inoguchi K, Khaleduzzaman M, Ninomiya Y, Ramirez F 1995 Developmental pattern of expression of the mouse α1 (XI) collagen gene (Col11a1). Dev Dyn 204:41-47.
33. Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ 1996 Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381:235-238.
34. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA, Williams T 1996 Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381:238-241.
35. Lefebvre V, de Crombrugghe B 1998 Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol 16:529-540.
36. Zhou G, Lefebvre V, Zhang Z, Eberspaecher H, de Crombrugghe B 1998 Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273:14989-14997.
37. Lefebvre V, Li P, de Crombrugghe B 1998 A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-5733.